Can Urol Assoc J. 2026 Jul 20. doi: 10.5489/cuaj.9576. Online ahead of print.
ABSTRACT
INTRODUCTION: A delay beyond 12 weeks from diagnosis to radical cystectomy (RC) is considered to impart worse oncologic outcomes for patients with muscle-invasive bladder cancer (MIBC); however, no randomized clinical trials have examined this question. We therefore emulated a hypothetical target clinical trial using contemporary data to evaluate the association between time from diagnosis to RC and oncologic outcomes.
METHODS: We conducted observational analyses using the National Cancer Database from 2006-2015 to emulate a hypothetical target trial in adults aged 40-79 years with incident cT2-4 N0 M0 urothelial carcinoma of the bladder, treated with RC from 4-18 weeks after diagnosis. We evaluated the association of late RC with pathologic upstaging at RC and overall survival (OS) and conducted exploratory analyses evaluating the association of time to RC with each outcome modeled flexibly.
RESULTS: A total of 3747 patients were included, of which 2992 underwent early RC. Median followup was 32.2 months. In adjusted analyses, late RC was not associated with an increased risk of pathologic upstaging compared to early RC. In addition, there was no statistically significant difference in adjusted OS for late and early RC, respectively. Similar findings were observed across categories of cT stage, age, Charlson index, and gender.
CONCLUSIONS: In observational analyses designed to emulate a hypothetical target trial of early vs. late RC, the timing of RC was not associated with a statistically significant increase in pathologic upstaging or a difference in OS when performed from 4-18 weeks after diagnosis. These results suggest the need to re-examine the traditional recommendations for timing of RC following diagnosis.
PMID:42531446 | DOI:10.5489/cuaj.9576
